Tutorials
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc

$ 12.79 +1.02 (+8.67%) 08:08 PM EST
P/E:
At Loss
P/B:
1.53
Market Cap:
$ 521.15M
Enterprise V:
$ 167.30M
Volume:
199.37K
Avg Vol (2M):
451.12K
Volume:
199.37K
Market Cap $:
521.15M
PE Ratio:
At Loss
Avg Vol (2-Month):
451.12K
Enterprise Value $:
167.30M
PB Ratio:
1.53
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

ALX Oncology Holdings Inc
NAICS : 541714 SIC : 2834
323 Allerton Avenue, South San Francisco, CA, USA, 94080
Description
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Name Current Vs Industry Vs History
Cash-To-Debt 291.5
Equity-to-Asset 0.91
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 18.62
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 71.74
9-Day RSI 64.63
14-Day RSI 62.45
6-1 Month Momentum % -36.02
12-1 Month Momentum % -85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.23
Quick Ratio 13.23
Cash Ratio 13.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -22.7

Financials (Next Earnings Date:2022-11-11 Est.)

ALXO's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ALXO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.72
Beta 0
Volatility % 80.34
14-Day RSI 62.45
14-Day ATR ($) 0.821418
20-Day SMA ($) 10.9585
12-1 Month Momentum % -85
52-Week Range ($) 5.82 - 81.19
Shares Outstanding (Mil) 40.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ALX Oncology Holdings Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More